In our study, HQ exposure upregulated the mRNA level of NFKB1 in chronic myeloid leukemia and acute myeloid leukemia pathway, which partly supported that HQ might promote leukemia development by activating the NF-κB pathway. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.